1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
General LOI Oct 1, 2026, full application Dec 7, 2026. Only Emory center still accepting: LOI Nov 16, 2026, full proposal Jan 25, 2027.
Call for Proposals: Randomized Clinical Trials on Behavioral Interventions in Aging is sponsored by The Edward R. Roybal Centers for Translational Research on Aging (Sponsored by National Institute on Aging (NIA)). The Roybal Program is accepting applications to fund fully powered, randomized clinical trials on behavioral interventions in aging.
Applicants must apply the NIH Stage Model as a conceptual framework and clearly articulate a plan for how their trial will progress through the NIH Stage Model. All clinical trials must have adequate statistical power to test mechanism of behavior change and/or efficacy of the intervention.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: US-based early-stage, mid-career and established investigators from academic, non-profit or corporate institutions. Confirm the full requirements in the official notice before applying.
Applications for Call for Proposals: Randomized Clinical Trials on Behavioral Interventions in Aging are due December 7, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Call for Proposals: Randomized Clinical Trials on Behavioral Interventions in Aging is funded by The Edward R. Roybal Centers for Translational Research on Aging (Sponsored by National Institute on Aging (NIA)). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
The National Institute on Aging's FY 2026 AD/ADRD portfolio consolidates the dementia research infrastructure layer — NCRAD, NACC, the new AI and Technology Collaboratory Coordinating Center — into a small number of large, often single-source cooperative agreements. The $113M new-research increment goes elsewhere. For investigators submitting in FY 2026, the structural change matters more than the headline dollar number.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article